Skip to main content
. 2020 Jan 21;11(3):294–299. doi: 10.18632/oncotarget.27323

Figure 2. MSCT two months after Elenagen and CMF chemotherapy treatment.

Figure 2

The lesion in chest soft tissue in upper left end is decreased in size.